Expanding Fertility Care to Poor and Low Resourced Settings Study
EXPLORE
1 other identifier
interventional
60
1 country
1
Brief Summary
The investigators currently lack an understanding of barriers to completing the male factor infertility evaluation. Furthermore, as the investigators continue to expand access to fertility treatment particularly within low-resourced settings, it is important that all aspects of infertility within a couple are equally explored. The COVID-19 pandemic has disproportionately affected low-income communities and communities of color at greater rates in terms of not only disease morbidity/mortality but how medical systems are accessed and care is delivered.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable healthy
Started May 2022
Longer than P75 for not_applicable healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 11, 2022
CompletedFirst Posted
Study publicly available on registry
January 25, 2022
CompletedStudy Start
First participant enrolled
May 24, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2024
CompletedFebruary 20, 2024
February 1, 2024
2 years
January 11, 2022
February 15, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To compare the time to complete the semen analysis with in-clinic versus at-home testing.
The time to completion between in-clinic versus at-home testing will be identified when the provider obtains the results.
3 months after consented to the study.
Secondary Outcomes (4)
To identify barriers to completing a semen analysis.
Three months after being consented to the study.
To compare barriers unique to completing an in-clinic versus at-home testing.
Three months after being consented to the study.
To compare satisfaction scores with in-clinic versus at-home testing.
Three months after being consented to the study.
To compare the time to initiating treatment after completing in-clinic versus at-home testing.
Six months after being consented to the study.
Study Arms (2)
In-Clinic Semen Analysis Testing
NO INTERVENTIONMen needing semen analysis for infertility work-up.
No in-clinic semen analysis testing
EXPERIMENTALMen needing semen analysis for infertility work-up.
Interventions
Presumably an easier, convenient, and more comfortable way to provide a semen analysis with an in-home mail-in semen analysis kit
Eligibility Criteria
You may qualify if:
- All English or Spanish speaking male partners of female patients undergoing an infertility work-up evaluation at Zuckerberg San Francisco General Hospital and recommended to undergo a semen analysis as a part of this workup.
You may not qualify if:
- If they do not speak English or Spanish they will be excluded
- If they are under the age of 18 y.o
- If they are not recommended to undergo a semen analysis as a part of the infertility evaluation
- If they are unable to produce a semen sample.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of California San Francisco
San Francisco, California, 94107, United States
Related Publications (5)
Bradshaw A, Ballon-Landa E, Owusu R, Hsieh TC. Poor Compliance With Postvasectomy Semen Testing: Analysis of Factors and Barriers. Urology. 2020 Feb;136:146-151. doi: 10.1016/j.urology.2019.10.026. Epub 2019 Nov 26.
PMID: 31778681BACKGROUNDPractice Committee of the American Society for Reproductive Medicine. Diagnostic evaluation of the infertile male: a committee opinion. Fertil Steril. 2015 Mar;103(3):e18-25. doi: 10.1016/j.fertnstert.2014.12.103. Epub 2015 Jan 15.
PMID: 25597249BACKGROUNDInfertility Workup for the Women's Health Specialist: ACOG Committee Opinion, Number 781. Obstet Gynecol. 2019 Jun;133(6):e377-e384. doi: 10.1097/AOG.0000000000003271.
PMID: 31135764BACKGROUNDEthics Committee of the American Society for Reproductive Medicine. Disparities in access to effective treatment for infertility in the United States: an Ethics Committee opinion. Fertil Steril. 2015 Nov;104(5):1104-10. doi: 10.1016/j.fertnstert.2015.07.1139. Epub 2015 Sep 10.
PMID: 26364838BACKGROUNDHerndon CN, Anaya Y, Noel M, Cakmak H, Cedars MI. Outcomes from a university-based low-cost in vitro fertilization program providing access to care for a low-resource socioculturally diverse urban community. Fertil Steril. 2017 Oct;108(4):642-649.e4. doi: 10.1016/j.fertnstert.2017.06.035. Epub 2017 Sep 2.
PMID: 28874259BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yanett Anaya, M.D.
University of California, San Francisco
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 11, 2022
First Posted
January 25, 2022
Study Start
May 24, 2022
Primary Completion
June 1, 2024
Study Completion
June 1, 2024
Last Updated
February 20, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share